Skip to main content

Investor Relations

Display

Home
Our Pipeline
Clinical Trials
CB-24 Mode of Action
Scientific Reviews
Press Release
The Team
Contact Us
Investor Relations

Reach Us

Our Office

38/39 Fitzwilliam Square West
Dublin 2, D02 NX53
Ireland

Get in Touch

Send us a message using the form below.

* Required

1. Your Name *

2. Your Email (required) *

3. Your Telephone

4. Organisation

5. Your Message

A clinical-stage biopharmaceutical company developing first-in-class venom-derived peptide therapies to transform patient outcomes.

Company

Our Pipeline Clinical Trials CB-24 Mode of Action Scientific Reviews The Team

Investors

Investor Relations Press Release Events

Contact

Get in Touch

© 2026 Celtic Biotech. All rights reserved.

Privacy Policy